Navigation Links
Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
Date:12/2/2008

minutes. It is ideally suited to both point-of-care testing and laboratory use. The RAMP(R) system consists of a Reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP(R) clinical tests are commercially available for the early detection of heart attack, congestive heart failure and influenza.

In late 2006, the Company formed a strategic alliance with 3M to commercialize rapid infectious disease tests worldwide and in 2008 entered into a strategic alliance with Roche Diagnostics to commercialize rapid cardiovascular tests worldwide.

In the non-clinical market, RAMP(R) Tests are currently provided for the environmental detection of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under development. Response has achieved CE Marking for its Reader and clinical tests and its Quality Management System is registered to ISO 13485: 2003 and ISO 9001: 2000. The RAMP(R) Influenza A/B Assay and RAMP 200 reader are not yet licensed for clinical use in Canada.

Response Biomedical is a publicly traded company, listed on the TSX under the trading symbol "RBM" and quoted on the OTC Bulletin Board under the symbol "RPBIF". For further information, please visit the Company's website at www.responsebio.com.

Statements contained in this press release relating to future results, events or developments, for example, statements containing the words "believes," "may," "could", "plans," "will," "estimate," "continue," "anticipates," "intends," "expects", "goal" and similar expressions, are "forward-looking statements" or "forward-looking information" under applicable United States and Canadian securities laws. Forward-looking statements or informati
'/>"/>

SOURCE Response Biomedical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Nordic Naturals Offers Cod Liver Oil Solutions in Response to Recent Vitamin A and Vitamin D Controversy
2. FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
3. Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governors Plea to Help the States Population in Need
4. Zimbabwean Health Workers Call For Crisis Response
5. TV News Story on Canine Cancer Generates Dog Lover Response - No. 1 Health Issue for Americas 40 Million Dog-Owning Households
6. iMedExchange Responses to Financial Crisis
7. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
8. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
9. Response Biomedical Closes $5.1 Million Financing
10. A useful imaging modality for monitoring treatment response to hepatocellular carcinoma
11. Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Before you start the grill, before you watch the ... Gifford and Hoda Kotb on the Today Show on Memorial Day. ... to Kathie Lee and Hoda, including the new LawnBott® LB75 robotic ... women in the military who made the ultimate sacrifice for us. ... with friends and family and enjoy the day. With a ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
(Date:5/24/2013)... hospitalized for heart failure appear to have better odds ... the morning, a new study finds. Death rates ... patients admitted in January, on Fridays and overnight, according ... findings Saturday in Portugal at the annual meeting of ... Cardiology. "The fact that patients admitted right ...
(Date:5/24/2013)... 24, 2013 ResortQuest Real Estate® is ... Dayna Feher team at the firm’s Bethany Beach location. ... resorts her home in 1975. Her real estate career ... all aspects of the real estate business - receptionist, ... 12 years, a licensed sales associate. , “I ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
Breaking Medicine News(10 mins):Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2
... new study finds an unusual side effect from drug ... signs of causing some patients to become excessive gamblers. ... the brain that allows people to have smooth movements. ... therapies for Parkinson’s focus on increasing dopamine. //Researchers at ...
... pollens can trigger asthma problems. A new study ... emergency hospital admissions than average. ,The research was ... this time, researchers tracked all hospital admissions for ... levels from trees and plants from 10 monitoring ...
... for human consumption may be needed to fight "a public ... of thousands of people, it was claimed last night. ... a disease commonly found in livestock and Crohn's disease,// a ... 600 of the population. ,Prof Hermon-Taylor is trying ...
... Johns Hopkins University surgeons performed three simultaneous kidney transplants ... nurses rushing organs in labeled coolers among six operating ... inside us," said one of the recipients.,The six synchronized ... implant them -- became possible after an extraordinarily lucky,// ...
... and Michelle Whitaker had what is believed to be ... a Chicago genetics institute. ,The new baby, named Jamie, ... genetically matched, while still an IVF embryo, to his ... anemia and his parents traveled to the United States ...
... announced the initial results of the three-year trial. ,The ... if it were 30 percent effective, but the reduction ... all racial groups, was 3.8 percent. ,A principal investigator ... a statistically significant reduction of HIV infection within the ...
Cached Medicine News:Health News:AIDS vaccine falls short but shows some promise 2
(Date:5/23/2013)... , May 24, 2013 3SBio ... the "Company"), a leading China ... and marketing biopharmaceutical products, announced today that, at ... the Company,s shareholders voted in favor of the ... agreement and plan of merger dated February 8, ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... PALO ALTO, Calif., Feb. 9, 2011 Telik, Inc. (Nasdaq: ... Wick, M.D., Ph.D. will provide a corporate overview at the ... City on Tuesday, February 15 at 3:00 p.m. Eastern time ... A live and archived webcast of the presentation will be ...
... MATEO, Calif., Feb. 8, 2011 NeurogesX, Inc. (Nasdaq: ... developing and commercializing novel pain management therapies, announced today ... scheduled to present at two upcoming conferences in New ... Investor Conference, to be held February 14-15, 2011 at ...
Cached Medicine Technology:NeurogesX to Present at Two February Investor Conferences 2NeurogesX to Present at Two February Investor Conferences 3
... innovative capillary electrophoresis system is designed ... testing. The CAPILLARYS 2 utilizes liquid ... clinical diagnostic setting. Through continuous sample ... very narrow capillary tubes functioning concurrently, ...
... These unique Acid Fast Control ... smear with appropriate background material. ... a positive and negative smear. ... (Cat. No. 353), Ziehl-Neelsen or ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Each slide contains Giardia lamblia trophozoites applied as a mono-layer to the side....
Medicine Products: